# Mitophagy as a therapeutic target for exercise-induced fatigue: modulation by natural compounds and mechanistic insights

**Authors:** Miao Yu, Xiujuan Jiang, Yingxin Zhang, Wensi Zhang, Tianlong Wang, Jialin Wang, Junwei Shao, Lixin Zhang, Yiting Sun, Xianglong Meng, Xiaohong Li, Xianjun Liu

PMC · DOI: 10.3389/fphys.2025.1664909 · 2025-10-31

## TL;DR

This paper explores how mitophagy, the process of removing damaged mitochondria, can be a target for treating exercise-induced fatigue, especially through natural compounds.

## Contribution

The paper introduces novel strategies for developing natural anti-fatigue agents by modulating mitophagy pathways.

## Key findings

- Mitophagy pathways like PINK1/Parkin and BNIP3/Nix are key in managing exercise-induced fatigue.
- Natural compounds such as sulforaphane and ginseng modulate mitophagy to reduce fatigue.
- A mitophagy threshold exists across different models, suggesting its therapeutic potential.

## Abstract

Exercise-induced fatigue is closely associated with mitochondrial dysfunction, and mitophagy plays a critical role in maintaining mitochondrial homeostasis by clearing damaged mitochondria and reducing oxidative stress. This review systematically summarizes current evidence on the regulatory mechanisms of mitophagy in exercise-induced fatigue, particularly through pathways such as PINK1/Parkin, BNIP3/Nix, FUNDC1, and AMPK, and examines how natural compounds including sulforaphane, Rhodiola crenulata, ginseng, modulate these pathways to alleviate fatigue. These findings suggest the presence of mitophagy threshold in different models and highlight its potential as a therapeutic target for fatigue management. Ultimately, this review proposes novel strategies for developing natural anti-fatigue agents based on mitophagy regulation, while underscoring the need for further mechanistic studies in diverse physiological and pathological settings.

## Linked entities

- **Genes:** PINK1 (PTEN induced kinase 1) [NCBI Gene 65018], park (parkin) [NCBI Gene 40336], BNIP3 (BCL2 interacting protein 3) [NCBI Gene 664], BNIP3L (BCL2 interacting protein 3 like) [NCBI Gene 665], FUNDC1 (FUN14 domain containing 1) [NCBI Gene 139341], PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562]
- **Chemicals:** sulforaphane (PubChem CID 5350)

## Full-text entities

- **Diseases:** mitochondrial dysfunction (MESH:D028361), fatigue (MESH:D005221)
- **Chemicals:** sulforaphane (MESH:C016766)
- **Species:** Rhodiola crenulata (da hua hong jing tian, species) [taxon 242839], Panax ginseng (Asiatic ginseng, species) [taxon 4054]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12615170/full.md

---
Source: https://tomesphere.com/paper/PMC12615170